{"id":1044,"date":"2011-07-28T00:00:00","date_gmt":"2011-07-28T00:00:00","guid":{"rendered":"http:\/\/www.innovationanthology.com\/import\/2018\/02\/01\/innovation-anthology-412\/"},"modified":"2018-02-25T21:30:27","modified_gmt":"2018-02-25T21:30:27","slug":"innovation-anthology-412","status":"publish","type":"post","link":"http:\/\/www.innovationanthology.com\/import\/2011\/07\/28\/innovation-anthology-412\/","title":{"rendered":"Innovation Anthology #412:"},"content":{"rendered":"<p><a href=\"http:\/\/innovationanthology.com\/uploads\/Innovation Anthology 412.mp3\">Download MP3 Link<\/a><\/p>\n<p> <strong>Cancer of the pancreas<\/strong> is one of the most difficult cancers to both diagnose and treat.   <\/p>\n<p> Standard treatment uses a chemotherapy called gemcitabine.  But it doesn&rsquo;t always work. <\/p>\n<p><strong> Dr. Jennifer Spratlin<\/strong> has received funding from Alberta Innovates Health Solutions and the Cancer Research Foundation to better target treatment for cancer patients who&rsquo;ve had surgery. <\/p>\n<p> As Dr. Spratlin explains, the key is whether a patient has a genetic biomarker called the hENT1 protein.    <\/p>\n<p><strong> DR. JENNIFER SPRATLIN: <\/strong><em>So we&rsquo;re looking at patients tumours first, and we&rsquo;re testing for this protein called  hENT1. If they have that protein, we expect that gemcitabine, the standard medicine, would work very well because it can get into cells.   If they do not have the protein or there&rsquo;s a low amount of protein,  they would then get the 5FU.  And what  we&rsquo;re expecting to see is that by selecting patients out using  this biomarker,   we would be able to make people live longer because they are getting a chemotherapy that attacks the cancer specifically and personalizes the medicine for themselves.  <\/em> <\/p>\n<p> In a second study, Dr. Spratlin will use the hENT1 biomarker to help determine  treatments with fewer side effects for patients with Stage 4 pancreatic cancer. <\/p>\n<p><em> Thanks today to <strong>Alberta Innovates Health Solutions<\/strong><\/em> <\/p>\n<\/p>\n<p> <strong>FOR INNOVATION ANTHOLOGY<br \/> I&rsquo;M CHERYL CROUCHER<\/strong> <\/p>\n<h2>Guest<\/h2>\n<h3> , <\/h3>\n<h4>, , , , <\/h4>\n<h2>Sponsor<\/h2>\n<h3><a href=\"http:\/\/www.aihealthsolutions.ca\">Alberta Innovates Health Solutions<\/a><\/h3>\n<p><font size=\"3\"><span style=\"font-weight: bold;\">Alberta Innovates (formerly Alberta Innovates &ndash; Health Solutions) <\/span><\/font><\/p>\n<p>As the newly formed Alberta Innovates corporation, we still fund top  quality, internationally competitive health&nbsp;research and innovation  activities to improve the health and wellbeing of Albertans.&nbsp;We provide  leadership for Alberta&rsquo;s health research and&nbsp;innovation enterprise by  directing, coordinating, reviewing, funding and supporting&nbsp;research and  innovation.<\/p>\n<p>Working&nbsp;with our many partners&nbsp; in the health system, we ensure that research achieves innovation  in&nbsp;care, policy and practice, and that the needs of patients and  clinicians influence&nbsp;research.<\/p>\n<h3>Our&nbsp;background<\/h3>\n<p><a href=\"http:\/\/albertainnovates.ca\/\" target=\"_blank\">Alberta Innovates<\/a> consolidation was launched November 1, 2016.<\/p>\n<p><strong>Alberta Innovates &ndash; Health Solutions<\/strong><\/p>\n<p>Alberta Innovates &ndash; Health Solutions was established as part of the Alberta Innovates system by an Act of Legislation of the Government of Alberta. It is a agency&nbsp;  of the Government of Alberta.&nbsp;We receive a yearly allocation from the  Ministry of Health and report through the ministry to the people of  Alberta.<\/p>\n<p>Our Mandate and Roles document reflects our role and responsibilities and outlines the government statues and regulations with which we comply.<\/p>\n<p>Alberta&rsquo;s Health Research and Innovation Strategy (AHRIS) sets out  Alberta&rsquo;s health research agenda for the coming decade to ensure our  considerable investments in research align with our priority&mdash;to improve  the health of Albertans.<\/p>\n<p>&nbsp;<\/p>\n<div class=\"et_pb_module et-waypoint et_pb_image et_pb_animation_off et_pb_image_3 et_always_center_on_mobile et_pb_image_sticky et-animated\"> \t\t\t\t<img decoding=\"async\" alt=\"\" src=\"http:\/\/albertainnovates.ca\/wp-content\/uploads\/2016\/10\/health_solutions_v2_icon.png\" \/> \t\t\t \t\t\t<\/div>\n<div class=\"et_pb_text et_pb_module et_pb_bg_layout_light et_pb_text_align_left  et_pb_text_2\">\n<p><strong>780-423-5727<br \/>Toll free: 1-877-423-5727<br \/><a href=\"http:\/\/aihealthsolutions.ca\">aihealthsolutions.ca<\/a><\/strong><\/p>\n<p>1500,<br \/>10104 &ndash; 103 Avenue<br \/>Edmonton, Alberta, Canada<br \/>T5J 4A7<\/p>\n<\/div>\n<p><img decoding=\"async\" src=\"http:\/\/innovationanthology.com\/uploads\/AI Health_AHFMR Tagline_RGB.jpg\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Program Date:<\/strong>\u00a02011-07-28<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancer of the pancreas is one of the most difficult cancers to both diagnose and treat.    Standard treatment uses a chemotherapy called gemcitabine.  But it doesn&rsquo;t always work.  <strong>Dr. Jennifer Spratlin<\/strong> has received funding from Alberta Innovates Health Solutions and the Cancer Research Foundation to better target treatment for cancer patients who&rsquo;ve had surgery. <em>(Alberta Innovates Health Solutions)<\/em><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55,2,27],"tags":[],"class_list":["post-1044","post","type-post","status-publish","format-standard","hentry","category-alberta-innovates-health-solutions","category-health-and-medicine","category-women-in-science","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/1044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/comments?post=1044"}],"version-history":[{"count":3,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/1044\/revisions"}],"predecessor-version":[{"id":4730,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/1044\/revisions\/4730"}],"wp:attachment":[{"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/media?parent=1044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/categories?post=1044"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/tags?post=1044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}